Mont-Saint-Guibert, Belgium – Celyad (Euronext Brussels and Paris, and NASDAQ:CYAD), a pioneer in the discovery and development of CAR-T cell therapies, today announced that Christian Homsy, Chief Executive Officer and David Gilham, VP Research and Development of Celyad will present a corporate update at the upcoming 29th Annual Piper Jaffray Healthcare Conference on Tuesday, November 28, 2017 at 4:30 p.m. ET in New York, NY.
A live audio webcast of the presentation is available here, where it will be archived for approximately 90 days.
